Gilead Sciences, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
18.28
Forward P/E Ratio
13.92
PEG Ratio
0.34
12.28
Price-to-Sales (TTM)
5.61
7.09
18.93
Market Cap
161.19B
180.90B
Is it profitable?
Net Profit Margin (TTM)
30.99%
Gross Profit Margin
79.24%
Diluted EPS (TTM)
7.35
43.36%
29.74B
Is it growing?
4.40%
53.70%
Is it risky?
0.34
94.64
1.97
22.17B
Who owns it?
92.26%
0.12%
1.92%
1.24B
1.24B
Does it pay?
2.53%
43.40%
Sep 12, 2024
Sep 27, 2024
How much cash?
9.82B
10.81B
7.93B
7.91
- Price
- 129.83
- Percent Change
- -5.01 (3.72%)
- Previous Close
- 134.84
- Open
- 135.01
- Low
- 129.26
- High
- 135.01
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$129.83
From 52W Low
+20.49%
From 52W High
-17.46%
Today
-3.72%
1Y Change
+15.83%
6M
$122.60
3M
$139.03
1M
$125.59
Today
$129.83
From 52W Low
+20.49%
From 52W High
-17.46%
Today
-3.72%
1Y Change
+15.83%
6M
$122.60
3M
$139.03
1M
$125.59
Today
$129.83
Fairly Priced
within its 1-year price range
$129.83
Multi-Timeframe Analysis (MTA)
Uptrend
Most timeframes point up. One conflicting period introduces some uncertainty, but the overall direction is positive. Weaker than a Strong Uptrend, but still a bullish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+3.4%
3M
-6.6%
6M
+5.9%
1Y
+15.8%
Rate of Change (ROC)
Insufficient price history
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Gilead Sciences, Inc.
- Founded
- 1987
- CEO
- Daniel Patrick O'Day
- Employees
- 17,000
- Fiscal Year End
- Dec 31, 2024
- Address
333 Lakeside Drive
Foster City
California
94404
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.gilead.com
Indicators
Operating Cash Flow
10.81B
Net Income
9.22B
Backed by Cash
1.17
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
NASDAQ 100Index NASDAQ-100 - NDX |
S&P 500Index S&P 500 - SPX |
Indicators
Operating Cash Flow
10.81B
Net Income
9.22B
Backed by Cash
1.17
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
18.28
Forward P/E Ratio
13.92
PEG Ratio
0.34
12.28
Price-to-Sales (TTM)
5.61
7.09
18.93
Market Cap
161.19B
180.90B
Is it profitable?
Net Profit Margin (TTM)
30.99%
Gross Profit Margin
79.24%
Diluted EPS (TTM)
7.35
43.36%
29.74B
Is it growing?
4.40%
53.70%
Is it risky?
0.34
94.64
1.97
22.17B
Who owns it?
92.26%
0.12%
1.92%
1.24B
1.24B
Does it pay?
2.53%
43.40%
Sep 12, 2024
Sep 27, 2024
How much cash?
9.82B
10.81B
7.93B
7.91
- Price
- 129.83
- Percent Change
- -5.01 (3.72%)
- Previous Close
- 134.84
- Open
- 135.01
- Low
- 129.26
- High
- 135.01
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
$129.83
From 52W Low
+20.49%
From 52W High
-17.46%
Today
-3.72%
1Y Change
+15.83%
6M
$122.60
3M
$139.03
1M
$125.59
Today
$129.83
From 52W Low
+20.49%
From 52W High
-17.46%
Today
-3.72%
1Y Change
+15.83%
6M
$122.60
3M
$139.03
1M
$125.59
Today
$129.83
Fairly Priced
within its 1-year price range
$129.83
Multi-Timeframe Analysis (MTA)
Uptrend
Most timeframes point up. One conflicting period introduces some uncertainty, but the overall direction is positive. Weaker than a Strong Uptrend, but still a bullish signal. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+3.4%
3M
-6.6%
6M
+5.9%
1Y
+15.8%
Rate of Change (ROC)
Insufficient price history
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Gilead Sciences, Inc.
- Founded
- 1987
- CEO
- Daniel Patrick O'Day
- Employees
- 17,000
- Fiscal Year End
- Dec 31, 2024
- Address
333 Lakeside Drive
Foster City
California
94404
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.gilead.com
Related Heatmaps
NASDAQ 100Index NASDAQ-100 - NDX |
S&P 500Index S&P 500 - SPX |